Throughout this medical market research, the publisher analyzed 18 dental bone graft substitutes companies in China and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of the China Dental Bone Graft Substitutes Market analysis, each of the market segments is also available for purchase as a stand-alone report, MedCore.
Markets Covered
Chinese Dental Bone Graft Substitutes Market Insights
Overall, the China dental bone graft substitutes and other biomaterials market was valued at $66.2 million in 2020. This is expected to increase over the forecast period at a CAGR of 28.8% to reach $389.5 million in 2027.
An ongoing trend within the market for dental biomaterials is the growth within the DBGS market, driven by unit sales growth in the allograft and xenograft segments. Growth in both segments is set to outpace the growth rate seen in the minor synthetic materials segment.
Geistlich, a globally recognized leader in regenerative materials, dominated the growing xenograft market in China. Geistlich’s success in the market has generated significant growth for xenograft materials, as the company is a globally recognized and trusted name. Through setting up an affiliate in China, the company has been able to combat local cultural barriers and build brand awareness in the market. The company is expected to maintain its share of the market, despite increasing competition from domestic companies.
While this MedSuite report contains all of the China Dental Bone Graft Substitutes Market analysis, each of the market segments is also available for purchase as a stand-alone report, MedCore.
Markets Covered
- Dental Bone Graft Substitutes Market - MedCore
- Dental Barrier Membranes Market - MedCore
Chinese Dental Bone Graft Substitutes Market Insights
Overall, the China dental bone graft substitutes and other biomaterials market was valued at $66.2 million in 2020. This is expected to increase over the forecast period at a CAGR of 28.8% to reach $389.5 million in 2027.
An ongoing trend within the market for dental biomaterials is the growth within the DBGS market, driven by unit sales growth in the allograft and xenograft segments. Growth in both segments is set to outpace the growth rate seen in the minor synthetic materials segment.
Geistlich, a globally recognized leader in regenerative materials, dominated the growing xenograft market in China. Geistlich’s success in the market has generated significant growth for xenograft materials, as the company is a globally recognized and trusted name. Through setting up an affiliate in China, the company has been able to combat local cultural barriers and build brand awareness in the market. The company is expected to maintain its share of the market, despite increasing competition from domestic companies.
Table of Contents
Table of ContentsList of FiguresList of ChartsExecutive SummaryChina Dental Bone Graft Substitute and Other Biomaterials Market OverviewCompetitive AnalysisMarket TrendsMarket DevelopmentsMarkets IncludedVersion HistoryAbbreviations
Research Methodology
Impact of COVID-19 on the China Dental Bone Graft Substitutes and Other Biomaterials Market
Disease Overview
Product Assessment
China Dental Bone Graft Substitute and Other Biomaterials Market Overview
Dental Bone Graft Substitute Market
Dental Barrier Membrane Market
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Allgens
- Beijing YHJ Science and Trade Co.
- Bicon
- Curasan
- DENTIS
- DSM
- Geistlich
- Genoss
- Halma
- Osteogenics
- Shanghai Rebone Biomaterials
- Shanxi OsteoRad
- Sunmax Biotechnology
- Sunstar
- Tianjin Sannie
- Tissue Banks
- Zhengzhou Smile Industrial
- Zimmer Biomet
